RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 111-121
  • American Ebola patients become serum test subjects

    American Ebola patients become serum test subjects
    There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
  • Use of experimental Ebola drug raises red flags among medical experts

    Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
  • Pfizer Slightly Beats Expectations, Leaves Investors Guessing About AstraZeneca

    Pfizer Inc on Tuesday left investors guessing whether it would renew its pursuit of its British rival, AstraZeneca, but said it was considering other deals. The largest U.S. drug maker reported higher-than-expected second-quarter revenue, helped by...
  • Poultry firms systematically feed low-dose antibiotics to flocks

    Poultry firms systematically feed low-dose antibiotics to flocks
    Major U.S. poultry firms are administering antibiotics to their flocks far more pervasively than regulators realize, posing a potential risk to human health. Internal records examined by Reuters reveal that some of the nation's largest poultry producers...
  • AbbVie sued by FTC for paying to delay generic drug

    AbbVie sued by FTC for paying to delay generic drug
    The Federal Trade Commission has filed suit against North Chicago-based AbbVie and a partner, alleging the companies illegally blocked consumer access to generic versions of the testosterone replacement drug AndroGel in order to reap hundreds of...
  • New drugs provide cure for hepatitis C, research finds

    Twenty-five years after scientists first identified the hepatitis C virus, doctors are declaring victory over an infection that afflicts more than 3 million Americans and kills more of them than HIV. In a series of clinical trial results, a new...
  • Takeda and Eli Lilly ordered to pay $9 billion over Actos drug

    A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos. The jury in Lafayette,...
  • Religion run amok? Hobby Lobby's case comes to the Supreme Court

    On Tuesday, the U.S. Supreme Court is slated to hear 90 minutes of oral arguments in a case that will determine whether bosses who have religious objections to birth control can deny their female employees the contraceptive coverage to which they are...
  • T. Rowe Price closes two popular funds to new investors

    T. Rowe Price closes two popular funds to new investors
    T. Rowe Price closed two funds focused on smaller companies to new investors Thursday, a move the firm said was designed to protect the traditionally risky funds from their own success. The assets of the roughly $15.5 billion New Horizons Fund, which...
  • Retirement: pushing the pause/restart buttons

    Kiplinger's Personal Finance Working past 66 may not be everyone's idea of a dream "retirement," but for many baby-boomers, it could represent the future. A 2013 Wells Fargo survey showed that one-third of respondents expect to work until "at least 80"...
  • NSU to open $80 million research center

    NSU to open $80 million research center
    Nova Southeastern University is expanding its role in research, building a new $80 million facility that could boost South Florida's efforts to become a hub for studies of cancer, heart disease and other problems. The Center for Collaborative Research,...